论文部分内容阅读
1 临床资料 1.1 一般性资料 1991年1月～1995年5月,经临床和或组织学证实,诊断肝硬化合并肝细胞癌(HCC)明确,资料完整的住院患者131例。年龄27～79岁,平均年龄53.8岁:男女比例为6:1。乙型肝炎后肝硬化121例,占92.35％。血清乙型肝炎病毒(HBV)标记物主要表现类性为:32.2％患者HbeAg及抗HBC两者均阳性,丙型肝炎病毒感染后肝硬化6例,占4.8％;原因不明肝硬化4例,占2.9％,AFP(RIA)>500ng/ml共53例,占40.4％;AFP≥200ng/ml者69例,占52.6％;AFP≤200ng/ml共53例,占40.4％
1 Clinical data 1.1 General Information January 1991 ~ May 1995, confirmed by clinical and or histological diagnosis of cirrhosis with hepatocellular carcinoma (HCC) clear, complete information in 131 cases of hospitalized patients. Aged 27 to 79 years, mean age 53.8 years: male to female ratio of 6: 1. Post-hepatitis B cirrhosis 121 cases, accounting for 92.35%. Serum hepatitis B virus (HBV) marker main performance class: 32.2% of patients were positive for HbeAg and anti-HBC, hepatitis C virus infection in cirrhosis in 6 cases, accounting for 4.8%; unknown cause cirrhosis in 4 cases, Accounting for 2.9%, AFP (RIA)> 500ng / ml in 53 cases, accounting for 40.4%; AFP≥200ng / ml in 69 cases, accounting for 52.6%; AFP≤200ng / ml in 53 cases, accounting for 40.4%